ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Technical Analysis

314 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is 0.62, suggesting ARS Pharmaceuticals is a Buy.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 15.11, while ARS Pharmaceuticals’s (SPRY) share price is $14.77, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 13.92, while ARS Pharmaceuticals’s (SPRY) share price is $14.77, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

Nov 05, 2024, 09:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.93
14.65
15.02
15.74
16.11
16.83
17.20
Fibonacci
14.65
15.06
15.32
15.74
16.15
16.41
16.83
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Nov 05, 2024, 09:24 AM
Period
Simple
Exponential
MA5
15.95Sell
15.55Sell
MA10
15.86Sell
15.54Sell
MA20
14.99Sell
15.11Sell
MA50
13.94Buy
13.92Buy
MA100
11.91Buy
12.43Buy
MA200
10.10Buy
10.28Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 15.54, while ARS Pharmaceuticals’s (SPRY) share price is $14.77, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 12.43, while ARS Pharmaceuticals’s (SPRY) share price is $14.77, making it a Buy.
ARS Pharmaceuticals’s (SPRY) stock price is $14.77 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 13.94, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $14.77 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 11.91, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $14.77 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 10.10, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Nov 05, 2024, 09:24 AM
Name
Value
Implied Action
RSI (14)
49.71
Neutral
STOCH (9,6)
43.03
Neutral
STOCHRSI (14)
55.85
Neutral
MACD (12,26)
0.62
Buy
ADX (14)
21.27
Neutral
Williams %R
-60.95
Buy
CCI (14)
9.67
Neutral
ATR (14)
0.88
-
Ultimate Oscillator
42.54
Neutral
ROC
8.13
Buy
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 49.71, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 21.27, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 9.67, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is 8.13, creating a Buy signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Hold.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 49.71, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is 0.62, which suggests SPRY is a Buy.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 15.95, which suggests SPRY is a Sell.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 14.99, which suggests SPRY is a Sell.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 13.94, which suggests SPRY is a Buy.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 10.10, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -60.95, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 9.67, which suggests SPRY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis